GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Shiller PE Ratio

Bristol-Myers Squibb Co (BSP:BMYB34) Shiller PE Ratio : 37.18 (As of May. 04, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Shiller PE Ratio?

As of today (2024-05-04), Bristol-Myers Squibb Co's current share price is R$221.98. Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2024 was R$5.97. Bristol-Myers Squibb Co's Shiller PE Ratio for today is 37.18.

The historical rank and industry rank for Bristol-Myers Squibb Co's Shiller PE Ratio or its related term are showing as below:

BSP:BMYB34' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.28   Med: 29.08   Max: 54.46
Current: 35.47

During the past years, Bristol-Myers Squibb Co's highest Shiller PE Ratio was 54.46. The lowest was 18.28. And the median was 29.08.

BSP:BMYB34's Shiller PE Ratio is ranked worse than
68.11% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.13 vs BSP:BMYB34: 35.47

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2024 was R$-29.331. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is R$5.97 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Shiller PE Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Shiller PE Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.35 48.49 43.84 43.29 26.98

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.63 35.04 30.89 26.98 43.73

Competitive Comparison of Bristol-Myers Squibb Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Shiller PE Ratio falls into.



Bristol-Myers Squibb Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bristol-Myers Squibb Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=221.98/5.97
=37.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-29.331/129.4194*129.4194
=-29.331

Current CPI (Mar. 2024) = 129.4194.

Bristol-Myers Squibb Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.447 100.560 0.575
201409 1.005 100.428 1.295
201412 0.026 99.070 0.034
201503 2.230 99.621 2.897
201506 -0.249 100.684 -0.320
201509 1.639 100.392 2.113
201512 -0.310 99.792 -0.402
201603 2.626 100.470 3.383
201606 2.362 101.688 3.006
201609 2.342 101.861 2.976
201612 1.778 101.863 2.259
201703 2.940 102.862 3.699
201706 1.845 103.349 2.310
201709 1.598 104.136 1.986
201712 -4.646 104.011 -5.781
201803 2.984 105.290 3.668
201806 0.867 106.317 1.055
201809 4.766 106.507 5.791
201812 2.835 105.998 3.461
201903 3.994 107.251 4.820
201906 3.354 108.070 4.017
201909 3.419 108.329 4.085
201912 -2.257 108.420 -2.694
202003 -1.661 108.902 -1.974
202006 -0.208 108.767 -0.247
202009 4.428 109.815 5.219
202012 -22.894 109.897 -26.961
202103 5.015 111.754 5.808
202106 2.363 114.631 2.668
202109 3.643 115.734 4.074
202112 6.051 117.630 6.657
202203 2.936 121.301 3.132
202206 3.331 125.017 3.448
202209 3.933 125.227 4.065
202212 4.983 125.222 5.150
202303 5.573 127.348 5.664
202306 4.805 128.729 4.831
202309 4.593 129.860 4.577
202312 4.263 129.419 4.263
202403 -29.331 129.419 -29.331

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BSP:BMYB34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bristol-Myers Squibb Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (BSP:BMYB34) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (BSP:BMYB34) Headlines

No Headlines